Newsfeeds - Spark Newswire

1 minute read

Auris Medical Stock Trading Higher After OligoPhore Technology Shows Tumor Inhibition In Animal Studies

June 21, 10:28 AM

Auris Medical Holding Ltd (NASDAQ:EARS) has announced the publication of positive results from an in vivo study employing its OligoPhore technology…

EARS

1 minute read

Auris Medical Enters RNA Therapeutics with Trasir Therapeutics Acquisition; Plans To Spin-Off/Divest Existing Programs

By Vandana Singh

June 3, 9:17 AM

Auris Medical Holding Ltd (NASDAQ:EARS) has acquired privately-held Trasir Therapeutics Inc, focused on extrahepatic oligonucleotide delivery. The purchase price comprises 0.77…

EARS

5 minute read

The Daily Biotech Pulse: Merck Completes Organon Spin-Off, Auris Repositions As RNA Therapeutic Company With Trasir Purchase, Replimune’s Readout

By Shanthi Rexaline

June 3, 8:23 AM

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs June 2)

AMYT

5 minute read

Uncategorized

70 Biggest Movers From Friday

By Lisa Levin

May 10, 5:24 AM

Gainers InnSuites Hospitality Trust (NYSE: IHT) shares gained 43.4% to close at $3.50 on Friday.

ADTN

4 minute read

Uncategorized

46 Biggest Movers From Yesterday

By Lisa Levin

April 21, 5:12 AM

Gainers

AGFY

Latest news

Auris Medical Stock Trading Higher After OligoPhore Technology Shows Tumor Inhibition In Animal Studies

Auris Medical Enters RNA Therapeutics with Trasir Therapeutics Acquisition; Plans To Spin-Off/Divest Existing Programs

The Daily Biotech Pulse: Merck Completes Organon Spin-Off, Auris Repositions As RNA Therapeutic Company With Trasir Purchase, Replimune’s Readout

70 Biggest Movers From Friday

46 Biggest Movers From Yesterday